Postural Low Back Pain Not Yet Recruiting Phase 3 Trials for Orphenadrine (DB01173)

IndicationStatusPhase
DBCOND0081268 (Postural Low Back Pain)Not Yet Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02985671To Evaluate the Superiority of Fixed Combination (Orfenadrine 35mg, Acetaminophen 325mg, Caffeine 65mg and Diclofenac Sodium 50mg) Compared to Voltaren® (Diclofenac Sodium 50mg) in the Treatment of Acute Postural Low Back Pain.Treatment